Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects

NCT02341183 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

COPD
Chronic Bronchitis

Interventions

DEVICE: tPAD
DEVICE: 7% hypertonic saline (510K approved as a device)

Sponsor

University of North Carolina, Chapel Hill